Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Biomaterials. 2013 Aug 12;34(34):8718–8725. doi: 10.1016/j.biomaterials.2013.07.068

Fig. 2.

Fig. 2

Enhanced binding of nano-carriers decorated with anti-CD30 antibody to CD30 positive SupM2 cells. A) The binding of Cy5.5 labeled CD30-targeted PEG-DSPE micelles to SUP-M2 cells. Cy5.5 labeled PEG-DSPE micelles were used as the non-targeted control. B) Cy5.5 labeled CD30-targeted Doxil® binding to SUP-M2 cells. Cy5.5 labeled Doxil® was used as the non-targeted control. These results are representative of three independent experiments